INTRODUCTION {#sec1-1}
============

Periodontal disease is a chronic immunoinflammatory disease, resulting from a complex interplay between periodontopathogens, their byproducts, and host response.\[[@ref1]\] It is characterized by the destruction of periodontal ligament and alveolar bone with subsequent clinical attachment loss. In periodontal disease, innate immunity is the first line of defense to bacterial challenge.\[[@ref2]\] Pathogen-associated pattern recognition receptors, mainly Toll-like receptors (TLRs), respond in a specific manner to lipopolysaccharides (LPSs) of Gram-negative bacteria.\[[@ref3]\] The destruction associated with periodontitis is attributed to the overactivation of TLRs. TLR-4 which is activated by LPS leads to the activation of nuclear factor (NF)κ-β and other inflammatory mediators. Most of the periodontal destruction is caused by these inflammatory mediators and activated free radicals.

The ultimate goal of periodontal therapy is to arrest bacteria/host-induced inflammation and maintain a healthy periodontium. Nonsurgical/surgical therapy has been the mainstay of periodontal disease management, and plaque control is considered as the cornerstone in the prevention of this chronic disease. Various chemical plaque control agents are used as adjuncts along with the mechanical debridement. Chemicals such as chlorhexidine (CHX), essential oils, and triclosan are also used as chemical plaque control agents, and they act as an adjunct to mechanical periodontal therapy.\[[@ref4]\]

At present, the most widely used and investigated chemical plaque control agent is CHX.\[[@ref5]\] The superior effect of CHX is due to its substantivity.\[[@ref6]\] CHX is accepted as a safe and effective antiplaque agent, but several studies showed that CHX is cytotoxic to many cells such as human dermal fibroblasts, gingival and periodontal ligament fibroblasts, and alveolar bone cells.\[[@ref7]\] Even low concentrations of CHX inhibited protein and DNA synthesis in fibroblasts and epithelial cells.\[[@ref8]\] *In vitro* studies have shown a time-dependent deleterious effect of CHX on cell viability and a dose-dependent toxic effect on cell proliferation.\[[@ref9][@ref10]\] Even though CHX is considered as the gold standard in chemical plaque control, the main concern is about its cytotoxicity to fibroblasts. Hence, an alternative agent with comparable antibacterial and anti-inflammatory property with less fibroblast cytotoxicity needs to be explored as a chemical plaque control agent.

Recently, phytotherapy (use of herbal agents as medicine) is gaining wide attention globally in medicine and dentistry because of its safety.\[[@ref11]\] Turmeric one of the widely used home remedies is being given more importance in medical research nowadays. The active ingredient of turmeric is curcumin, and it is a lipophilic polyphenol extracted from the root of curcumin longa.\[[@ref12]\] Curcumin possesses anti-inflammatory, antibacterial, antioxidant, and immunomodulatory properties and promotes wound healing.\[[@ref13]\] In periodontal disease, curcumin modulates NF-κβ following TLR-4 activation by LPS.\[[@ref14]\] Curcumin suppresses an array of cytokines and downregulates several enzymes such as inducible nitric oxide synthase, cyclooxygenase-2 (COX-2), and lipoxygenase.\[[@ref15]\] They are potent scavengers of reactive oxygen species that give an added benefit in periodontal disease. Curcumin inhibits the growth of many periodontopathogens in a dose-dependent manner.\[[@ref16]\]

To the best of the authors\' knowledge, only a few studies\[[@ref11][@ref14]\] are available in the literature evaluating the effect of curcumin on fibroblast cytotoxicity and wound healing. This study was conducted to compare the effect of curcumin and CHX digluconate on human fibroblast cell viability and migration.

MATERIALS AND METHODS {#sec1-2}
=====================

Sample size (n) calculation:

The sample size was calculated based on a previous study\[[@ref10]\] using the formula,
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Where Z~a~ = 1.96 (constant), Z~b~ = 0.84 (constant), SD = Standard deviation = 11, and d = Effect size = 10.

According to this, the sample size in each category was calculated as 20. For cytotoxic evaluation, the sample size calculated was 200 (twenty samples for each concentration of curcumin \[0.003%, 0.03%, 0.06%, 0.1%, and 0.12%\] and CHX \[0.03%, 0.06%, 0.1%, 0.12%, and 0.2%\]). For scratch wound assay, 60 samples were taken. In this *in vitro* study, the total sample size was calculated as 260.

Test materials {#sec2-1}
--------------

The test materials used for this study are commercially available CHX digluconate 0.2% and curcumin powder (99% pure curcumin, Sigma Aldrich, St. Louis, US). CHX concentrations used in this study were 0.03%, 0.06%, 0.1%, 0.12%, and 0.2%, and concentrations of curcumin used in this study were 0.003%, 0.03%, 0.06%, 0.1%, and 0.12%.

In this study, the following procedures were conducted to compare the effect of curcumin and CHX digluconate on human fibroblast cell viability and migration.

Preparation of compound stockAntibacterial testingCulturing of fibroblastCytotoxicity evaluationEvaluation of cell proliferation and migration/wound healing (scratch wound assay).

### Preparation of compound stock {#sec3-1}

Curcumin and CHX digluconate stock solutions were diluted to a series of concentrations using Dulbecco\'s Modified Eagle Medium (DMEM) and dissolved completely by cyclomixer. The solution was filtered through a 0.22-μm Millipore syringe to ensure sterility.

### Antibacterial testing (determination of minimum inhibitory concentration (MIC50) of test materials) {#sec3-2}

The minimum inhibitory concentration (MIC50) was determined before the evaluation of cytotoxicity and wound healing property. MIC50 was determined using a two-fold serial dilution method.\[[@ref17]\] A 28-g nutrient broth media (HiMedia) was dissolved in 1000-ml distilled water and was autoclaved at 121°C, 15l bps for 15 min. Mixed culture of bacteria (*Streptococcus mutans* \[MTCC 890\] and Enterococcus faecalis \[ATCC 29212\]) was used as a test inoculum. The growth of test inoculum was adjusted to 1% McFards Standard. The broth dilution assay was done in 96-well microtiter plates (Thermo Scientific). All wells in the plate were added with 100 μl of the diluted (two times) inoculum suspensions (final volume in each well was 200 μl). Samples of both CHX and curcumin were added in increasing concentrations to the respective wells and incubated overnight at 37°C in a microbiological incubator (KEMI). The control well (with bacteria) was also incubated without any test materials. Bacterial growth was observed by visual inspection and by measuring the optical density (OD) at 630 nm using enzyme-linked immunosorbent assay plate reader (ERBA, LisaScan). The OD was measured immediately after the visual reading. The growth inhibition for the test wells at each extract dilution was determined by the formula:

Percentage of inhibition = (OD of control − OD of test)/(OD of control) × 100%.

The results were obtained as percentage inhibition of bacteria corresponding to the concentration of the test solution (curcumin and CHX). MIC50 and lethal dose (LD90) of curcumin and CHX were further calculated using ED50 plus v1 software (AATBioquest, Californi, USA) from the result obtained.

### Culturing of fibroblast {#sec3-3}

Human dermal pulp stem cells were initially procured from HiMedia, India (National Centre for Cell Sciences, Pune, Maharashtra, India). They were cultured in HiMesoXL™ mesenchymal stem cell expansion medium. It is supplemented with 10% mesenchymal stem cell tested fetal bovine serum, L-glutamine, sodium bicarbonate, and antibiotic solution containing penicillin (100U/ml) streptomycin (100 μg/ml) and amphotericin B (2.5 μg/ml). To convert stem cells to gingival fibroblast cells, the cells were trypsinized and cultured in HiFibroXL™ fibroblast expansion medium. Two-day-old confluent monolayer cells are trypsinized, and the cells are suspended in a 10% growth medium. A 100-μl cell suspension (5 × 10^4^ cells/well) was seeded in 96-well tissue culture plates and incubated at 37°C in a humidified 5% CO~2~ incubator. The cells obtained by this procedure were used for carrying out 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for cytotoxicity evaluation and scratch wound assay.

### Cytotoxicity evaluation {#sec3-4}

After attaining sufficient growth of fibroblast cells, the growth medium is removed. Freshly prepared solutions of CHX (0.03%, 0.06%, 0.1%, 0.12%, and 0.2%) and curcumin (0.003%, 0.03%, 0.06%, 0.1%, and 0.12%) in 100-μl 5% DMEM are added in triplicates to the respective wells and incubated for 1, 2, 4, 6, 8, and 10 min at 37°C in a humidified 5% CO~2~ incubator. The viability of cells is evaluated by direct microscopic observation through inverted phase-contrast microscopy and MTT assay.

Cytotoxicity evaluation by direct microscopic observation

After 24 h of incubation of fibroblasts, with varying concentrations of CHX (0.03%, 0.06%, 0.1%, 0.12%, and 0.2%) and curcumin (0.003%, 0.03%, 0.06%, 0.1%, and 0.12%), the entire plate is observed in an inverted phase-contrast tissue culture microscope (Olympus CKX41 with Optika Pro5 CCD Camera). Microscopic observations were recorded as images for each concentration of curcumin and CHX at varying time periods. Each concentration at a varying time period of both CHX and curcumin was imaged. Any detectable changes in the morphology of cells were considered as indications of cytotoxicity.

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay

A 15-mg MTT (Sigma, M-5655) is reconstituted in 3-ml phosphate buffer saline (PBS) until completely dissolved and sterilized by filter sterilization. The fibroblasts with varying concentrations of CHX (0.03%, 0.06%, 0.1%, 0.12%, and 0.2%) and curcumin (0.003%, 0.03%, 0.06%, 0.1%, and 0.12%) were incubated for 24 h. A 30-μl reconstituted MTT solution was added to all test and control wells. The plate is then shaken well and then incubated at 37°C in a humidified 5% CO~2~ incubator for 4 h. After the incubation period, the supernatant is removed and 100 μl of MTT solubilization solution diethyl sulfoxide is added and the wells are mixed gently by pipetting up and down in order to solubilize the formazan crystals. The absorbance values are measured using a microplate reader at a wavelength of 540 nm. The same procedure was repeated in twenty samples, provided all other conditions are kept similar.

The percentage of cell viability was calculated using the formula:

Percentage of viability = Mean OD samples × 100/Mean OD of the control group (OD = Optical Density)

The result obtained was the mean percentage of viability of fibroblasts corresponding to each concentration of curcumin and CHX at varying time periods.

### Scratch wound assay {#sec3-5}

The scratch wounds were made by a sterile 1-ml pipette tip through a premarked line in the fibroblast culture plates. After removal of the resulting debris from five linear scratches, the cell monolayer was subsequently rinsed three times with PBS (phosphate buffer solution) followed by incubation with samples at antibacterial concentration -- CHX -- 0.1% and curcumin -- 0.003% for 24, 48, and 72 h. The control plate was also incubated without any test materials. Twenty similar culture plates were prepared for both curcumin and CHX. The wound areas were displayed by taking images after staining with acridine orange, just above the interchanges between scratched wound areas and premarked lines. The effect of the sample on wound closure was determined microscopically (Olympus CKX41) after 24, 48, and 72 h of incubation. The effect of the sample on wound closure was measured in terms of the area using MRI-Image J analysis software (Javabased image processing program, (National institute of health and LOCI, University of Wisconsin)). The wound closure was calculated as percentage migration of fibroblast in CHX, curcumin, and control samples at 24, 48, and 72 h.

Statistical analysis {#sec2-2}
--------------------

Mean (±SD) was calculated for all quantitative variables. Intergroup comparison of mean percentage of fibroblast viability at the antibacterial concentration of CHX and curcumin at the varying time periods and intergroup comparison of mean percentage of fibroblast migration and proliferation (wound healing) of control, CHX, and curcumin at varying time periods were calculated by one-way ANOVA. Repeated measures ANOVA was used for intragroup comparison of mean percentage of fibroblast viability at different concentrations of control, CHX, and curcumin at each time period and intragroup comparison of mean percentage of fibroblast migration and proliferation of control, CHX, and curcumin at varying time periods. Bonferroni *post hoc* test was done. The α value was set at 0.05 and the confidence interval set at 95%.

RESULTS {#sec1-3}
=======

This experimental study focused on five different concentrations of curcumin and CHX at six different time periods. An antibacterial test was carried out to assess the MIC of both curcumin and CHX. A series of concentrations were tested against different strains of bacteria. MIC50 of curcumin was 0.003% \[[Figure 1](#F1){ref-type="fig"}\] and of CHX was 0.1% \[[Figure 2](#F2){ref-type="fig"}\]. As the concentration of CHX and curcumin increased, the antibacterial property was also found to be increased. Curcumin showed MIC at a very low concentration (0.003%) as compared to CHX. This study suggested that the antibacterial property of curcumin was higher than that of CHX.

![Percentage inhibition of bacteria at different concentrations of CUR on mixed bacterial culture. The MIC50 of CUR was 0.1% and LD90 was 0.01%. Calculated by software -- ED50plus V (CUR -- Curcumin; MIC -- Minimum inhibitory concentration; LD -- Lethal dose)](JISP-24-109-g002){#F1}

![Percentage inhibition of bacteria at different concentrations of CHX on mixed bacterial culture. The MIC50 of CHX was 0.1% and LD90 was 0.18%. Calculated by software -- ED50plus v (CHX -- Chlorhexidine; MIC -- Minimum inhibitory concentration; LD -- Lethal dose)](JISP-24-109-g003){#F2}

The MTT assay was carried out to evaluate the gingival fibroblast cytotoxicity of curcumin and CHX. It was observed that the mean percentage of fibroblast viability decreases as the concentration of CHX (0.03%, 0.06%, 0.1%, 0.12%, and 0.2%) and curcumin (0.003%, 0.03%, 0.06%, 0.1%, and 0.12%) increases at varying time periods. As the time period increases (1, 2, 4, 6, 8, and 10 min), the mean percentage of fibroblast viability decreases for both agents. At 0.1% concentration of CHX (MIC50), the mean percentage of fibroblast viability ranges from 48.75% to 38.85% for the time period of 1--10 min. At 0.003% concentration of curcumin (MIC50), the mean percentage of fibroblast viability ranges from 99.04% to 68.6% for the time period of 1--10 min. For all other concentrations of curcumin, the fibroblast viability is less than the viability at the concentration of 0.003% for the time period of 1--10 min. The mean percentage of fibroblast viability of curcumin was significant at all concentrations at varying time periods except at a concentration of 0.06% (*P* \< 0.05) \[[Table 1](#T1){ref-type="table"}\]. The mean percentage of fibroblast viability was not significant at all concentrations of CHX at varying time periods (*P* \> 0.05) \[[Table 1](#T1){ref-type="table"}\].

###### 

Mean percentage of fibroblast viability at different concentrations of chlorhexidine and curcumin at varying time periods

  Samples (%)   Mean percentage of fibroblast viability (%)   Intragroup comparison                                                     
  ------------- --------------------------------------------- ----------------------- -------- ------- -------- ------- ------- ------- ---------
  CHX 0.03      77.99                                         71.178                  65.64    63.23   57.12    53.62   7.623   1.565   0.064
  CHX 0.06      58.50                                         57.55                   52.15    49.02   43.94    43.43   1.745   3.059   0.170
  CHX 0.1       48.75                                         47.54                   40.55    39.73   39.34    38.85   5.423   1.483   0.103
  CHX 0.12      42.85                                         40.01                   37.26    35.08   34.59    34.22   2.797   1.275   0.216
  CHX 0.2       36.23                                         33.93                   31.79    31.32   30.24    30.08   2.978   1.582   0.185
  CUR 0.003     99.04                                         90.80                   77.031   74.04   72.41    68.66   97.24   1.460   0.000\*
  CUR 0.03      90.77                                         85.68                   75.73    72.88   70.484   65.44   56.17   1.110   0.013\*
  CUR 0.06      72.19                                         67.69                   64.85    63.84   63.62    63.46   4.039   1.549   0.137
  CUR 0.1       56.43                                         52.60                   50.950   49.74   46.66    45.89   11.69   1.860   0.025\*
  CUR 0.12      39.23                                         36.99                   35.77    34.29   34.10    32.82   7.438   1.939   0.048\*

\**P*\<0.05 significant. The mean percentage of fibroblast viability of CUR was significant at all concentrations except at concentration of 0.06% at different time periods. (Repeated measures ANOVA, *P*\<0.05). The mean percentage of fibroblast viability was not significant at all concentrations of CHX at varying time periods. (Repeated measures ANOVA, *P*\>0.05). Intragroup comparison of mean percentage of fibroblast viability at different concentrations of CHX and CUR at different time periods was statistically significant. (One-way ANOVA, *P*\<0.05). CHX -- Chlorhexidine; CUR -- Curcumin;*P* -- Probability value; *F* -- Fstatistic

There was a significant difference in the mean percentage of fibroblast viability between CHX and curcumin at different concentrations (0.03%, 0.06%, 0.1% and 0.12%) at varying time periods (*P* \< 0.05) \[[Table 1](#T1){ref-type="table"}\]. Curcumin showed a higher mean percentage of fibroblast viability as compared to CHX at every concentration and time period. There was a significant difference between mean percentage of fibroblast viability at the antibacterial concentration of CHX (0.1%) and curcumin (0.003%) at different time periods (*P* \< 0.05) \[[Table 2](#T2){ref-type="table"} and [Graph 1](#G1){ref-type="fig"}\]. Bonferroni *post hoc* analysis showed that there was a significant difference in the mean percentage of fibroblast viability between the antibacterial concentration of curcumin and CHX at varying time periods.

###### 

Comparison of mean percentage of fibroblast viability at antibacterial concentration of chlorhexidine (0.1%) and curcumin (0.003%) at varying time periods

  Samples (%)   Mean fibroblast viability (%) and SD   Comparison between antibacterial concentration                                                                                 
  ------------- -------------------------------------- ------------------------------------------------ -------------- -------------- -------------- -------------- --------- ------- ---------
  CHX 0.1       48.76 (5.64)                           47.55 (5.62)                                     40.56 (5.80)   39.74 (5.58)   39.34 (4.59)   38.86 (3.10)   102.841   11.24   0.000\*
  CUR 0.003     99.05 (.54)                            90.80 (.126)                                     77.03 (1.16)   74.05 (.08)    72.40 (.43)    68.66 (1.35)                     

\**P*\<0.05 significant. The mean percentage fibroblast viability at antibacterial concentration of CHX (0.1%) and CUR (0.003%) at different time periods was statistically significant (One-way ANOVA, *P*\<0.05). Bonferroni *post hoc* analysis showed that there was a significant difference in the mean percentage of fibroblast viability. CHX -- Chlorhexidine; CUR -- Curcumin; SD -- Standard deviation; *P* -- Probability value; *F* -- Fstatistic

![Comparison of mean percentage fibroblast viability at antibacterial concentration of chlorhexidine (0.1%) and curcumin (0.003%) at varying time period. \**P* \< 0.05 significant. The mean percentage fibroblast viability at antibacterial concentration of CHX (0.1%) and CUR (0.003%) at different time periods was statistically significant (One-way ANOVA, *P* \< 0.05). Bonferroni *post hoc* analysis showed that there was a significant difference in the mean percentage of fibroblast viability. CHX -- Chlorhexidine; CUR -- Curcumin; SD -- Standard deviation; *P* -- Probability value; *F* -- Fstatistic](JISP-24-109-g004){#G1}

In this study, morphological change of CHX/curcumin-treated fibroblasts was evaluated through a phase-contrast microscope. As the concentration of CHX increased from 0.03% to 0.2%, changes such as nuclear fragmentation, cytoplasmic blebbing, and echinoid spikes were visible. At the antibacterial concentration of CHX (0.1%), fibroblast exhibited alteration in normal morphology of cells, cell shrinkage and presence of apoptotic cells, but normal morphology of cells was reflected at an antibacterial concentration of curcumin \[[Figure 3](#F3){ref-type="fig"}\]. As the concentration of curcumin increased minor alteration in the morphology of cells such as loss of spindle shape of cells and cell shrinkage were seen, but was not appreciable.

![Phase-contrast microscopic images of gingival fibroblasts exposed to varying concentrations of CHX and CUR at 1-min time period. CHX 0.03% -- Alteration in spindle-shaped appearance of fibroblasts. 0.06% -- Hyperchromatic nuclei/cell shrinkage. 0.1% -- Nuclear condensation 0.12% -- Cell morphology completely lost, presence of apoptotic bodies. 0.2% -- Membrane blebbing/Apoptotic bodies/Echinoid spikes. CUR 0.003% -- No changes. 0.03%/0.06% -- Cell shrinkage hyperchromatism. 0.1% -- Cellular condensation. Membrane blebbing present. 0.12% -- Presence of apoptotic bodies. (CHX -- Chlorhexidine; CUR -- Curcumin)](JISP-24-109-g005){#F3}

The wound healing property of CHX and curcumin was compared by carrying out a scratch wound assay for three different time periods (24, 48, and 72 h). The mean percentage of fibroblast migration and proliferation (wound healing) of CHX at the 24^th^, 48^th^, and 72^nd^ h was 8.93%, 9.67%, and 10.44%, respectively, whereas the mean percentage of fibroblast migration and proliferation of curcumin at the 24^th^, 48^th^, and 72^nd^ h was 17.6%, 26.58%, and 40.92%, respectively. The mean percentage of fibroblast migration and proliferation (wound healing) of control, CHX, and curcumin at different time periods is statistically significant (*P* \< 0.05) \[[Table 3](#T3){ref-type="table"}, [Figure 4](#F4){ref-type="fig"} and [Graph 2](#G2){ref-type="fig"}\]. Intergroup comparison showed that the mean percentage of fibroblast migration and proliferation between control, CHX, and curcumin at the 24^th^, 48^th^, and 72^nd^ h was statistically significant (*P* \< 0.05) \[[Table 3](#T3){ref-type="table"}\]. The mean percentage of fibroblast migration and proliferation of curcumin at MIC was higher as compared to CHX (0.1%). The mean percentage of fibroblast migration and proliferation of CHX (0.1%) is found to be lower than that of control. Bonferroni *post hoc* analysis of the mean percentage of fibroblast migration and proliferation between control, CHX (0.1%), and curcumin (0.003%) shows statistical significance at varying time periods.

###### 

The mean percentage of fibroblast migration and proliferation (wound healing) of control, chlorhexidine, and curcumin at varying time periods

  Samples   Mean percentage of fibroblast migration and proliferation (wound healing)   Intragroup comparison   Intergroup comparison                                                   
  --------- --------------------------------------------------------------------------- ----------------------- ----------------------- ---------- ------- --------- --------- -------- ---------
  Control   2.70                                                                        14.42                   22.13                   4.747E10   1.328   0.000\*   8.67E10   11.228   0.000\*
  CHX       8.93                                                                        9.66                    10.44                   1.569E10   2.551                                
  CUR       17.6                                                                        26.58                   40.92                   3.166E11   2.280                                

\**P*\<0.05 significant. Intragroup comparison (repeated measures ANOVA *P*\<0.05) and intergroup comparison (one-way ANOVA *P*\<0.05) of mean percentage of fibroblast migration and proliferation of control, CHX, and CUR at varying time periods was statistically significant. CHX -- Chlorhexidine; CUR -- Curcumin; *P*-- Probability value; *F* -- Fstatistic

![Images of acridine orange stained gingival fibroblasts exposed to CHX and CUR at 24, 48 and72 h of incubation. (×4, Olympus CKX41). The mean percentage of fibroblast migration and proliferation of control 24^th^, 48^th^, and 72^nd^ h was 2%, 14%, and 22%, respectively. The mean percentage of fibroblast migration and proliferation of CHX at 24^th^, 48^th^, and 72^nd^ h was 8.93%, 9.67%, and 10.44%, respectively. The mean percentage of fibroblast migration and proliferation of CUR at 24^th^, 48^th^, and 72^nd^ h was 17.6%, 26.58%, and 40.92%, respectively. (CHX -- Chlorhexidine; CUR -- Curcumin)](JISP-24-109-g006){#F4}

![The mean percentage fibroblast migration and proliferation (wound healing) of control, chlorhexidine and curcumin at varying time period. \**P* \< 0.05 significant. Intragroup comparison (repeated measures ANOVA *P* \< 0.05) and intergroup comparison (one-way ANOVA *P* \< 0.05) of mean percentage of fibroblast migration and proliferation of control, CHX, and CUR at varying time periods was statistically significant. CHX -- Chlorhexidine; CUR -- Curcumin; *P* -- Probability value; *F* -- Fstatistic](JISP-24-109-g007){#G2}

DISCUSSION {#sec1-4}
==========

At present, the most widely used and investigated chemical plaque control agent is CHX digluconate.\[[@ref5]\] The most effective commercially available concentration of CHX as an antiplaque agent is 0.12% and 0.2%.\[[@ref1]\] Literature gives sufficient evidence regarding the toxic nature of CHX when it is used as an antimicrobial mouthwash adjunct to surgical/nonsurgical periodontal therapy. Recently, many studies have documented the antibacterial, anti-inflammatory, immunomodulatory, and wound healing properties of curcumin.\[[@ref13]\] The studies evaluating the effect of curcumin on fibroblast cytotoxicity and wound healing property are scarce in the literature.

The concentrations selected for carrying out cytotoxicity and wound healing studies were based on the antibacterial activity of CHX and curcumin. The MIC50 calculated for CHX was 0.1% and that of curcumin was 0.003% (30 μg/ml). The MIC of CHX exhibited a 33.33-fold increase in concentration as compared to MIC of curcumin for effective bacterial inhibition. In literature, many studies are available to support the antibacterial property of curcumin at the concentration (MIC50) obtained in the present study.\[[@ref16][@ref18][@ref19]\]

Curcumin possesses both bacteriostatic and bacteriocidal properties against a wide range of pathogenic microorganisms.\[[@ref19]\] The antibacterial property of curcumin is attributed to its chemical structure. Curcumin is a lipophilic polyphenol insert into the lipid bilayer of bacterial cell wall which enhances cell permeability.\[[@ref20]\] It inhibits bacterial cell division, biofilm formation, and maturation.\[[@ref18]\] Curcumin inhibits Porphyromonas gingivalis proteases (RGP and KGP) in a dose-dependent manner.\[[@ref16]\] It possesses a high absorptive affinity to hydroxyapatite and salivary proteases that can be related to its increased local availability in the oral cavity and can be more or less compared to the substantivity of CHX.\[[@ref18]\]

Fibroblasts are considered as the main architect-builders of periodontal tissue.\[[@ref21]\] The effect of antibacterial mouthwashes on growth, survival, migration, and proliferation of these fibroblasts has to be well evaluated when these agents are used as an adjunct to mechanical periodontal therapy. In this study, a dose-dependent reduction in the mean fibroblast viability was observed after treating with CHX and curcumin. Among the concentrations of CHX and curcumin, the lowest concentration (0.03% and 0.003%, respectively) expressed the highest mean fibroblast viability. The fibroblast viability of curcumin at each concentration was highest compared to all similar concentrations of CHX at varying time intervals. CHX was more cytotoxic to gingival fibroblast at all concentrations that we have studied as compared to curcumin. Cline and Layman in 1992 studied the viability of fibroblasts with increasing concentration of CHX, and they observed a significant reduction of viability of fibroblast in a concentration-dependent manner.\[[@ref22]\] CHX even in low concentration was toxic for a variety of human cells including gingival fibroblasts.\[[@ref8]\]

Studies regarding fibroblast cytotoxicity of curcumin are scarce in the literature. Liu *et al*.\[[@ref23]\] assayed the effect of curcumin on human fibroblasts and suggested that curcumin did not show any cytotoxic effects. Many comparative studies\[[@ref10][@ref24][@ref25]\] were discussed in the literature regarding the fibroblast cytotoxicity of CHX with other chemotherapeutic agents. All of these studies (*in vitro*) are pointing to the fact that CHX is highly cytotoxic and suggests the cautious use of CHX.

In this study, morphological changes of fibroblasts treated with CHX and curcumin were compared. It was evident that CHX exhibited severe toxic changes in fibroblast morphology in a dose- and time-dependent manner as compared to curcumin. In accordance with these observations, Pucher and Daniel in 1992\[[@ref9]\] and Cline and Layman in 1992\[[@ref22]\] observed that gingival fibroblast on treatment with 0.2% CHX appeared rounded and retracted from culture dishes.

Recently, clinical trials regarding the effectiveness of curcumin in patients with periodontal disease are emerging in literature. Waghmare *et al*.\[[@ref26]\] in 2011, Arunachalam *et al*.\[[@ref27]\] in 2017, and Chatterjee *et al*. in 2017\[[@ref28]\] compared the antiplaque effect of CHX and curcumin mouthrinse, and they reported that curcumin mouthrinse can be considered as an alternative antiplaque agent to CHX. One of the limitations observed in all these studies was that no standardization of concentrations of curcumin in terms of MIC was undertaken. Even though curcumin is a naturally occurring polyphenol, at high concentrations it is found to be highly cytotoxic and leads to apoptosis of cells a property that embarks its use as an anticancer drug.\[[@ref29]\]

Normally periodontal tissue cell turnover involves the generation of new cells by proliferation and migration. Fibroblast contributes to the periodontal tissue homeostasis by their ability to remodel tissues and to repopulate wounds. For successful periodontal therapy and predictable regeneration, the presence of viable and healthy cells of the periodontium is essential and these cells should adhere to the root surfaces of the teeth. The antimicrobial mouthwash, when used as an adjunct to mechanical therapy or as a subgingival irrigant, should not produce a deleterious effect on the fibroblasts.

In the scratch wound assay, it was observed that the wound healing property of curcumin was higher as compared to CHX and control. Several investigators have reported a delay in wound healing after exposure to varying concentrations of CHX.\[[@ref9][@ref30]\] The delay in wound healing may be either due to the death of fibroblast which impairs its migration and proliferation or due to a marked reduction in protein synthesis.\[[@ref30]\] Conflicting reports are also available in the literature regarding wound healing property of CHX. Egelberg *et al*.\[[@ref31]\] suggested that topically applied CHX did not interfere with gingival wound healing in dogs. The varying results that appeared in the literature regarding the effect of CHX on wound healing may be due to diverse study models employed. Hence, the true mechanism underlying the effect of CHX in contact with surgical wounds must be further evaluated both at the molecular and biological levels before reaching a valid conclusion.

The wound healing property of curcumin can be best explained by its antibacterial, anti-inflammatory, and immunomodulating properties. Curcumin is proven to be a potent antimicrobial agent that is effective against a range of organisms. Curcumin suppresses the activation of the transcription factor NF-κB,\[[@ref11]\] downregulates the expression of LPS-induced of COX-2, inhibits an array of cytokines,\[[@ref14]\] reduces the expression of various vascular endothelial cell surface adhesins, and decreases the formation of prostaglandin E2,\[[@ref32]\] which is a potent stimulator of bone resorption and a key player in periodontal disease. Curcumin reduces LPS-induced interferon regulatory factor 3 activation and TLR4 signaling by arresting both myeloid differentiation factor 88 (MyD88) and the transient receptor(TR) domain-containing adaptor-inducing interferon-β-dependent pathways.\[[@ref23]\] Curcumin is also considered as a very potent antioxidant.\[[@ref33]\] It is a free radical scavenger and hydrogen donor and exhibits both pro- and antioxidant activity.\[[@ref34]\] Curcumin-mediated fibroblast migration may be induced by Dkk-1-associated regulation of Wnt signaling.\[[@ref23]\] Curcumin is a potent inhibitor of matrix metalloproteinases and an array of cytokines, which reduces the destructive inflammatory process during wound healing enabling more and more cells to migrate and proliferate. It is also possible that curcumin may induce healing by regulating gene expression at posttranscriptional level and is found to be important for cell migration and proliferation.\[[@ref32]\]

The design of the present study is *in vitro* research, and the evidence provided may not be strong. The study was carried out on gingival fibroblast cultured from dental pulp stem cells, and further studies can be carried out using both gingival and periodontal ligament fibroblasts.

CONCLUSIONS {#sec1-5}
===========

Successful periodontal therapy has been centered on reducing the microbial load by mechanical/antimicrobial therapy, and modulating the host response. Curcumin has a wide biological spectrum that could provide an alternative anti-inflammatory, antimicrobial, and immunomodulatory agent for managing chronic periodontitis which is an immunoinflammatory disease. Within the limitations of the present study, it can be concluded that 0.003% of curcumin exhibits the least fibroblast cytotoxicity, effective inhibition of bacteria, and proper wound healing. Curcumin may offer as a more cost-effective, less cytotoxic, easily available antiplaque agent.
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